Lumibird S.A.
Lumibird S.A. (0FRI.L) Stock Overview
Explore Lumibird S.A.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
417.1M
P/E Ratio
73.24
EPS (TTM)
$0.19
ROE
0.03%
0FRI.L Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Lumibird S.A. (0FRI.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 63.63, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.41.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 73.24 and a market capitalization of 417.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Lumibird SA engages in the design, manufacturing and marketing of lasers. The company is headquartered in Lannion, Bretagne and currently employs 541 full-time employees. The firm offers a range of products, including compact pulsed Nd, double-pulse Nd, tunable laser systems, flash-lamp pumped lasers, diode-pumped solid-state lasers, semiconductor laser modules and intense pulsed light instruments, among others. Lumibird provides lasers to industrial and scientific clients, as well as the medical sector, among others. The firm operates worldwide through the subsidiaries, such as Quantel Medical, which specializes in the development and marketing of diagnostic ocular ultrasound systems and surgical lasers; Quantel USA, which designs and produces fiber lasers, glass laser systems and tunable lasers, and Quantel Derma AT, which focuses on the development, production and sales of the laser technology products in the areas of dermatology and aesthetics.
Marc Le Flohic
1,027
2 rue du Paul Sabatier, Lannion
2016